Get started
Author

Michele Ferrara

Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice
2013 · Paolo E. Porporato, Nicoletta Filigheddu, et al. · Journal of Clinical Investigation · 190
PDF
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy
2021 · Giorgia Careccia, Marielle Saclier, et al. · Science Translational Medicine · 51
Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions
2020 · Michele Ferrara, Ginevra Chialli, et al. · Frontiers in Immunology · 50
PDF
Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene
2022 · Michele Ferrara, Maria Samaden, et al. · Frontiers in Cell and Developmental Biology · 44
PDF
Diacylglycerol kinase α mediates 17-β-estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell line through the G protein-coupled estrogen receptor GPR30
2011 · Nicoletta Filigheddu, Sara Sampietro, et al. · Cellular Signalling · 38
The Diacylglycerol Kinase α/Atypical PKC/β1 Integrin Pathway in SDF-1α Mammary Carcinoma Invasiveness
2014 · Elena Rainero, Cristina Cianflone, et al. · PLoS ONE · 34
PDF
Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model
2017 · Simone Reano, Elia Angelino, et al. · Stem Cells · 29
PDF
Ghrelin knockout mice display defective skeletal muscle regeneration and impaired satellite cell self-renewal
2018 · Elia Angelino, Simone Reano, et al. · Endocrine · 18
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers
2025 · Margherita Rimini, Lorenzo Fornaro, et al. · Liver International · 13
PDF
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
2023 · Francesco Maria Venanzi, Marta Bini, et al. · Cancer Treatment Reviews · 13
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index
2025 · Mara Persano, Margherita Rimini, et al. · Liver International · 11
PDF
Antifibrotic Activity of Acylated and Unacylated Ghrelin
2015 · Elia Angelino, Simone Reano, et al. · International Journal of Endocrinology · 11
PDF
HIF-1α Directly Controls WNT7A Expression During Myogenesis
2020 · Federica Cirillo, Giulia Resmini, et al. · Frontiers in Cell and Developmental Biology · 10
PDF
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience
2024 · Francesca Rita Ogliari, Alberto Traverso, et al. · Lung Cancer · 6
Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis
2025 · Sara Oresti, Fabio Salomone, et al. · EClinicalMedicine · 4
PDF
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ ‐1 Study Eligibility: A Large Global Analysis in a Real‐World Setting
2026 · Federica Lo Prinzi, Margherita Rimini, et al. · International Journal of Cancer · 1
PDF
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab
2026 · Margherita Rimini, Angela Lamarca, et al. · International Journal of Cancer · 1
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab
2026 · Silvia Camera, Lorenzo Fornaro, et al. · Targeted Oncology · 1
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study
2025 · Federica Lo Prinzi, Federico Rossari, et al. · Hepatology Research · 1
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy
2026 · Linda Bartalini, Margherita Rimini, et al. · Cancers
Overall and Line-Specific Impact of Targeted Therapies in Advanced Biliary Tract Cancer After Chemoimmunotherapy Failure
2026 · Margherita Rimini, Masafumi Ikeda, et al. · Journal of Hepatology
Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non–small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial—HYPERBOLIC Study
2026 · Ludovica Mollica, Elena Tassi, et al. · Clinical Lung Cancer
Benchmarking Missing-Data-Native Survival Models in a Real-World Metastatic NSCLC Cohort — the AI-HOPE Lung Cancer Study
2026 · Francesca Rita Ogliari, Donato Tiano, et al. · Research Square
PDF
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
2026 · Andrea Casadei-Gardini, Terry Cheuk-Fung Yip, et al. · European Journal of Cancer
Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study
2026 · Giulia Pasello, Claudia Proto, et al. · Frontiers in Oncology
PDF
Works count: 31
Citation count: 525
H-index: 11
I10-index: 13
Year
Topic
Type